227 related articles for article (PubMed ID: 31413354)
21. Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: a 10-year experience of the Geisinger Medical Center.
Fata F; Mirza A; Craig G; Nair S; Law A; Gallagher J; Ellison N; Bernath A
Cancer; 2002 Apr; 94(7):1931-8. PubMed ID: 11932894
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer.
Verhoeff SR; van Erning FN; Lemmens VE; de Wilt JH; Pruijt JF
Int J Cancer; 2016 Jul; 139(1):187-93. PubMed ID: 26914273
[TBL] [Abstract][Full Text] [Related]
23. Association of chemotherapy with survival in stage II colon cancer patients who received radical surgery: a retrospective cohort study.
Lv Z; Liang Y; Liu H; Mo D
BMC Cancer; 2021 Mar; 21(1):306. PubMed ID: 33757442
[TBL] [Abstract][Full Text] [Related]
24. T4 stage and preoperative anemia as prognostic factors for the patients with colon cancer treated with adjuvant FOLFOX chemotherapy.
An MS; Yoo JH; Kim KH; Bae KB; Choi CS; Hwang JW; Kim JH; Kim BM; Kang MS; Oh MK; Hong KH
World J Surg Oncol; 2015 Feb; 13():64. PubMed ID: 25889520
[TBL] [Abstract][Full Text] [Related]
25. Oncologic Outcomes of Oral Adjuvant Chemotherapy Regimens in Stage III Colon Cancer: Tegafur-Uracil Plus Leucovorin Versus Capecitabine.
Tashiro J; Yamaguchi S; Ishii T; Kondo H; Hara K; Shimizu H; Takemoto K; Suzuki A
Clin Colorectal Cancer; 2017 Sep; 16(3):e141-e145. PubMed ID: 28216247
[TBL] [Abstract][Full Text] [Related]
26. Does delay of adjuvant chemotherapy impact survival in patients with resected stage II and III colon adenocarcinoma?
Bayraktar UD; Chen E; Bayraktar S; Sands LR; Marchetti F; Montero AJ; Rocha-Lima CM
Cancer; 2011 Jun; 117(11):2364-70. PubMed ID: 24048783
[TBL] [Abstract][Full Text] [Related]
27. High-risk clinicopathological features and their predictive significance in Korean patients with stage II colon cancer.
Park JS; Chon HJ; Jeung HC; Shin SJ; Rha SY; Ahn JB; Lee KY; Kim NK; Chung HC
J Cancer Res Clin Oncol; 2016 Sep; 142(9):2051-9. PubMed ID: 27447697
[TBL] [Abstract][Full Text] [Related]
28. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study.
Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO
J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors and the role of adjuvant chemotherapy in post-curative surgery for Dukes B and C colon cancers and survival outcomes: a Malaysian experience.
Hassan AS; Naicker M; Yusof KH; Wan Ishak WZ
Asian Pac J Cancer Prev; 2015; 16(6):2237-43. PubMed ID: 25824744
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant Fluorouracil, Leucovorin, and Oxaliplatin in Stage II to III Colon Cancer: Updated 10-Year Survival and Outcomes According to BRAF Mutation and Mismatch Repair Status of the MOSAIC Study.
André T; de Gramont A; Vernerey D; Chibaudel B; Bonnetain F; Tijeras-Raballand A; Scriva A; Hickish T; Tabernero J; Van Laethem JL; Banzi M; Maartense E; Shmueli E; Carlsson GU; Scheithauer W; Papamichael D; Möehler M; Landolfi S; Demetter P; Colote S; Tournigand C; Louvet C; Duval A; Fléjou JF; de Gramont A
J Clin Oncol; 2015 Dec; 33(35):4176-87. PubMed ID: 26527776
[TBL] [Abstract][Full Text] [Related]
31. Complete Obstruction, a Real Risk Factor: A Comprehensive Study on Obstruction in Stage IIA Colon Cancer With Propensity Score Matching Analysis.
Oh SY; Kim CW; Kim S; Kim MH; Kim YI; Lee JL; Yoon YS; Park IJ; Lim SB; Yu CS
Clin Colorectal Cancer; 2024 Jun; 23(2):135-146.e3. PubMed ID: 38749791
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant chemotherapy for stage III colon cancer in the oldest old: results beyond clinical guidelines.
Abraham A; Habermann EB; Rothenberger DA; Kwaan M; Weinberg AD; Parsons HM; Gupta P; Al-Refaie WB
Cancer; 2013 Jan; 119(2):395-403. PubMed ID: 22806931
[TBL] [Abstract][Full Text] [Related]
33. The prognostic value of signet ring cell histology in stage I/II colon cancer-a population-based, propensity score-matched analysis.
Ackermann CJ; Guller U; Jochum W; Schmied BM; Warschkow R
Int J Colorectal Dis; 2018 Sep; 33(9):1183-1193. PubMed ID: 29881972
[TBL] [Abstract][Full Text] [Related]
34. Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea.
Kim JY; Kim YJ; Lee KW; Lee JS; Kim DW; Kang SB; Lee HS; Jang NY; Kim JS; Kim JH
Jpn J Clin Oncol; 2013 Feb; 43(2):132-8. PubMed ID: 23204187
[TBL] [Abstract][Full Text] [Related]
35. Effect of Adjuvant Chemotherapy on Elderly Stage II High-Risk Colorectal Cancer Patients.
Lee Y; Park I; Cho H; Gwak G; Yang K; Bae BN
Ann Coloproctol; 2021 Oct; 37(5):298-305. PubMed ID: 34228912
[TBL] [Abstract][Full Text] [Related]
36. Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy.
Hung HY; Chen JS; Yeh CY; Changchien CR; Tang R; Hsieh PS; Tasi WS; You JF; You YT; Fan CW; Wang JY; Chiang JM
Int J Colorectal Dis; 2011 Aug; 26(8):1059-65. PubMed ID: 21479566
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer.
Cakar B; Varol U; Junushova B; Muslu U; Gursoy Oner P; Gokhan Surmeli Z; Cirak Y; Karaca B; Sezgin C; Karabulut B; Uslu R
J BUON; 2013; 18(2):372-6. PubMed ID: 23818348
[TBL] [Abstract][Full Text] [Related]
38. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.
Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD
J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521
[TBL] [Abstract][Full Text] [Related]
39. Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer.
Bos AC; van Erning FN; van Gestel YR; Creemers GJ; Punt CJ; van Oijen MG; Lemmens VE
Eur J Cancer; 2015 Nov; 51(17):2553-61. PubMed ID: 26360411
[TBL] [Abstract][Full Text] [Related]
40. Conventional adverse features do not predict response to adjuvant chemotherapy in stage II colon cancer.
Peng SL; Thomas M; Ruszkiewicz A; Hunter A; Lawrence M; Moore J
ANZ J Surg; 2014 Nov; 84(11):837-41. PubMed ID: 24224835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]